Penn Medicine Study Points to Financial and Racial Barriers to Biologic Treatments for Medicare Patients with Moderate to Severe Psoriasis
Perelman School of Medicine at the University of PennsylvaniaIn the first known study to examine the prevalence and treatment of psoriasis in older Americans, experts from the Perelman School of Medicine at the University of Pennsylvania have found that black patients receiving Medicare are less likely to receive biologic therapies –medications derived from human or animal cells or tissues – for the treatment of moderate to severe psoriasis than white patients.